Report cover image

Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report

Publisher MarketLine
Published Jan 28, 2022
Length 53 Pages
SKU # MTLN17000194

Description

Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage biopharmaceutical company. The company classifies its business into a single business: the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases. The company’s marketed products include Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO); Mepsevii for treatment of mucopolysaccharidosis VII (MPS VII, Sly syndrome); and Dojolvi for treatment of long-chain fatty acid oxidation disorders (LC-FAOD). It is also developing two pipeline products including, DTX301 for the treatment of ornithine transcarbamylase (OTC) deficiency; and DTX401 for treatment of glycogen storage disease type 1a (GSDIa). The company through its subsidiaries operates in the UK, Switzerland, the US, Germany, Brazil, Argentina, Netherlands, France, Colombia, Canada, and Mexico. Ultragenyx is headquartered in Novato, California, the US

Scope
  • Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments
  • Intelligence on Ultragenyx Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Ultragenyx Pharmaceutical Inc.'s business structure, strategy and prospects.

Table of Contents

53 Pages
Company Snapshot
Ultragenyx Pharmaceutical Inc.: Company Overview
Ultragenyx Pharmaceutical Inc.: Overview and Key Facts
Ultragenyx Pharmaceutical Inc.: Overview
Ultragenyx Pharmaceutical Inc.: Key Facts
Ultragenyx Pharmaceutical Inc.: Key Employees
Ultragenyx Pharmaceutical Inc.: Key Employee Biographies
Ultragenyx Pharmaceutical Inc.: Major Products and Services
Ultragenyx Pharmaceutical Inc.: Company History
Ultragenyx Pharmaceutical Inc.: Management Statement
Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
Ultragenyx Pharmaceutical Inc.: Key Competitors
Ultragenyx Pharmaceutical Inc.: Company Analysis
Ultragenyx Pharmaceutical Inc.: Business Description
Ultragenyx Pharmaceutical Inc.: SWOT Analysis
Ultragenyx Pharmaceutical Inc.: SWOT Overview
Ultragenyx Pharmaceutical Inc.: Strengths
Ultragenyx Pharmaceutical Inc.: Weaknesses
Ultragenyx Pharmaceutical Inc.: Opportunities
Ultragenyx Pharmaceutical Inc.: Threats
Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity
Ultragenyx Pharmaceutical Inc.: Financial Deals Overview
Ultragenyx Pharmaceutical Inc.: Targets and Partners
Ultragenyx Pharmaceutical Inc.: Top Deals 2018 - 2022YTD*
Ultragenyx Pharmaceutical Inc.: Advisors
Ultragenyx Pharmaceutical Inc.: Top Legal Advisors
Ultragenyx Pharmaceutical Inc.: Top Financial Advisors
Ultragenyx Pharmaceutical Inc.: Capital Raising
Ultragenyx Pharmaceutical Inc.: Partnership
Ultragenyx Pharmaceutical Inc.: Divestments
Ultragenyx Pharmaceutical Inc.: Recent Developments
Ultragenyx Pharmaceutical Inc.: News and Events Summary
Ultragenyx Pharmaceutical Inc.: Corporate Governance
Ultragenyx Pharmaceutical Inc.: Financial Performance
Ultragenyx Pharmaceutical Inc.: Market Developments
Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts
Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees
Table 3: Ultragenyx Pharmaceutical Inc.: Company History
Table 4: Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
Table 5: Ultragenyx Pharmaceutical Inc.: Key Competitors
Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Ultragenyx Pharmaceutical Inc.: Targets and Partners
Table 9: Ultragenyx Pharmaceutical Inc.: Top Deals 2018 - 2022YTD*
Table 10: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 13: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 14: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 15: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 16: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 17: Ultragenyx Pharmaceutical Inc.: News and Events Summary
Table 18: Ultragenyx Pharmaceutical Inc.: Corporate Governance
Table 19: Ultragenyx Pharmaceutical Inc.: Financial Performance
Table 20: Ultragenyx Pharmaceutical Inc.: Market Developments
Table 21: Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
List of Figures
Figure 1: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 4: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 5: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 6: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 7: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us